Rethinking a Market Category Built for Execution, Not Economic Performance

Introduction

Patient financial performance is one of the most economically strained and structurally difficult areas of consumer payment in the United States.[1] Yet it remains largely organized as an RCM execution problem because healthcare extended payer-oriented billing logic to the patient.

This essay introduces Economic Intelligence as the governing decision layer for patient financial performance. It moves engagement, payment terms, financing, collections, and other RCM actions downstream from economic diagnosis—reversing a traditional sequence that often acts first and determines financial fit later.

Market Misdiagnosis: The Category Failure

Despite advances in estimates, payment options, engagement, automation, and AI, patient financial performance remains structurally weak.[2] The failure is not simply weak collections. It is how the market has framed the problem.

Patient financial engagement evolved from insurance-billing logic: identify the balance, issue the statement, apply a workflow, and escalate if payment is not received. Yet the fit is imperfect. That sequence was designed for payer claims governed by contractual obligations—not patient balances shaped by household economics, payment choice, and uncertain recovery.

Unlike an insurance claim, a patient balance is only a stated obligation. It does not reveal what is realistically recoverable, why payment may fail, what pursuit will cost, or which pathway is most likely to convert the obligation into revenue.

The patient-provider revenue path is the strategy—the route most likely to generate realized value given patient capacity, recovery probability, cost, timing, and expected yield.

That is the category error: the market has organized itself around the visible problem—the unpaid balance—rather than the underlying revenue opportunity.

Reframing the Problem: A Two-Player Economic Game

Viewed through the lens of economics rather than RCM operating logic, the patient-payment decision becomes a two-player game. The provider manages the revenue process; the patient decides whether payment appears to be a rational use of limited household resources relative to competing priorities—and therefore controls the decisive economic move.

The root problem is not execution alone. It is a condition of behavioral economics and strategic asymmetry: one participant designs and operates the process, while the other retains the decisive choice.

The provider can issue statements, initiate outreach, offer payment options, and escalate collection activity, but none of those actions compels the patient to convert the obligation into revenue.

The revenue challenge is therefore to configure the pathway most likely to produce a rational payment decision for that specific patient and balance while generating the strongest attainable revenue value.

Revenue value is not simply the amount collected. It is the expected recoverable yield after accounting for payment probability, patient capacity, cost, timing, compliance, and the risk of value loss.

Market Correction: Defining Economic Intelligence

Economic Intelligence is the discipline of diagnosing the financial condition of an encounter, comparing the available revenue pathways, and determining which action is most likely to produce the greatest attainable patient-provider revenue value.

Like clinical diagnosis, it does not confuse inputs with conclusions or interventions with diagnosis. That distinction matters because much of the market may reasonably believe these capabilities already exist. Providers already use propensity models, affordability indicators, segmentation, eligibility tools, payment plans, financing, financial assistance, automation, AI, and increasingly sophisticated workflow platforms.

Economic Intelligence performs a different function. It interprets those inputs together, evaluates the available pathways as competing economic alternatives based on the expected revenue value of each, and determines which action is most likely to produce the strongest outcome for that specific patient and balance.

Economic Intelligence in Action

Economic Intelligence begins with a fundamental operating-model change: patient financial services and RCM must move beyond treating every account primarily as a balance to be billed and collected and begin managing patient receivables as financial assets with different values, risks, costs, and conversion opportunities.

The practical equivalent is a patient-financial EHR. Just as the clinical record brings together history, symptoms, tests, and diagnoses to guide treatment, the financial record assembles the economic inputs needed to guide the appropriate revenue strategy for each encounter.

Economic Intelligence then works through three steps.

1. Establish the Economic Condition

Relevant inputs—including balance composition, coverage, household capacity, affordability indicators, prior payment behavior, assistance eligibility, timing, pursuit cost, and available pathways—are assembled into a unified encounter-level financial record.

The objective is not simply to collect more data. It is to differentiate among possible financial conditions and establish the condition that should govern the account's treatment.

2. Determine Expected Recoverable Value

Each available pathway is evaluated as a distinct economic alternative according to payment probability, expected yield, cost, timing, patient burden, compliance, and risk.

The objective is to determine the expected recoverable value of the account under each possible pathway—not simply its stated balance or collection propensity. A large balance with limited capacity, low conversion probability, and high pursuit cost may represent less economic value than a smaller balance with a stronger probability of payment and lower resolution cost.

3. Configure, Prioritize, and Direct the Highest-Yield Path

Economic Intelligence does not indiscriminately apply balance-based payment plans, financing offers triggered by billing-cycle timing, generic engagement programs, or collection strategies designed primarily around RCM cost efficiency. Those approaches treat the bill—not the patient or the revenue opportunity.

The result is a shift from collection sequencing to active portfolio management: directing each account toward the strategy with the strongest patient fit, highest rational yield, and greatest likelihood of converting recoverable value before it is delayed, diluted, or lost.

Market-Forward: From Execution to Economic Performance

Economic Intelligence moves the governing decision upstream by managing patient receivables as financial assets and directing RCM according to expected recoverable value. It does not replace execution; it gives execution the economic diagnosis and direction required to produce stronger financial outcomes.

References

1. This characterization reflects widely documented payment polarization, household affordability pressure, medical-debt burden, and persistent patient-payment underperformance. The Consumer Financial Protection Bureau has documented medical debt as a significant source of consumer financial distress, while KFF estimates that Americans owe at least $220 billion in medical debt and reports that four in ten adults carry some form of medical or dental debt. Federal Reserve research likewise shows that unexpected medical expenses and outstanding medical debt remain persistent household financial burdens. See: Consumer Financial Protection Bureau, Medical Debt Burden in the United States, March 2022; KFF, The Burden of Medical Debt in the United States, February 2024, and Americans' Challenges with Health Care Costs, April 2026; Board of Governors of the Federal Reserve System, Economic Well-Being of U.S. Households in 2025, May 2026.
2. Kodiak Solutions reported that overall patient collection yield declined slightly despite improvements in point-of-service financial engagement, indicating that stronger execution does not necessarily translate into stronger financial performance. A 2025 JAMA Health Forum study of 30.7 million patient episodes likewise found that more than 92% ended in either no payment or full payment, reflecting the persistent weakness and polarization of patient-payment outcomes.